140 related articles for article (PubMed ID: 24518391)
1. A surprising diagnosis: metastatic prostate cancer causing cervical lymphadenopathy.
Lad M; Sharma A; Patten DK
BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24518391
[TBL] [Abstract][Full Text] [Related]
2. Presentation of prostate carcinoma with cervical lymphadenopathy: report of three cases.
Wang HJ; Chiang PH; Peng JP; Yu TJ
Chang Gung Med J; 2004 Nov; 27(11):840-4. PubMed ID: 15796261
[TBL] [Abstract][Full Text] [Related]
3. [A case of prostatic adenocarcinoma clinically presenting as supraclavicular and mediastinal lymphadenopathy].
Tsujino K; Sasada S; Kawahara K; Terada H; Komori C; Suzuki H; Okamoto N; Kobayashi M; Hirashima T; Matsui K; Kawase I
Nihon Kokyuki Gakkai Zasshi; 2007 Aug; 45(8):648-53. PubMed ID: 17763696
[TBL] [Abstract][Full Text] [Related]
4. Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases.
Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Saeid MS; Young CY; Klee GG; Tindall DJ; Bostwick DG
Urology; 1999 May; 53(5):939-44. PubMed ID: 10223487
[TBL] [Abstract][Full Text] [Related]
5. Fine needle aspiration biopsy diagnosis of metastatic prostate carcinoma to inguinal lymph node.
Rosa M; Chopra HK; Sahoo S
Diagn Cytopathol; 2007 Sep; 35(9):565-7. PubMed ID: 17703448
[TBL] [Abstract][Full Text] [Related]
6. Metastatic prostate carcinoma presenting as supraclavicular lymphadenopathy - is it unusual?
Ahamed SH; Agarwal AK; Raju PP
Ann R Coll Surg Engl; 2006 Oct; 88(6):W4-5. PubMed ID: 17059705
[TBL] [Abstract][Full Text] [Related]
7. 10-year survival of a patient with metastatic prostate cancer: Case report and literature review.
Krpina K; Markić D; Rahelić D; Ahel J; Rubinić N; Španjol J
Arch Ital Urol Androl; 2015 Sep; 87(3):252-3. PubMed ID: 26428652
[TBL] [Abstract][Full Text] [Related]
8. A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy.
Iwamura H; Hatakeyama S; Tanaka Y; Tanaka T; Tokui N; Yamamoto H; Imai A; Yoneyama T; Hashimoto Y; Koie T; Yoshikawa K; Ohyama C
BMC Res Notes; 2014 Jan; 7():64. PubMed ID: 24476098
[TBL] [Abstract][Full Text] [Related]
9. The loss of 5alpha-reductase type I and type II mRNA expression in metastatic prostate cancer to bone and lymph node metastasis.
Habib FK; Ross M; Bayne CW; Bollina P; Grigor K; Chapman K
Clin Cancer Res; 2003 May; 9(5):1815-9. PubMed ID: 12738739
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer: Molecular lymph node analysis for prognostication.
Kelsey R
Nat Rev Urol; 2018 Apr; 15(4):205. PubMed ID: 29508845
[No Abstract] [Full Text] [Related]
11. Association of time to prostate-specific antigen nadir and logarithm of prostate-specific antigen velocity after progression in metastatic prostate cancer with prior primary androgen deprivation therapy.
Teoh JY; Tsu JH; Yuen SK; Chiu PK; Chan SY; Wong KW; Ho KL; Hou SS; Ng CF; Yiu MK
Asian J Androl; 2017; 19(1):98-102. PubMed ID: 26585698
[TBL] [Abstract][Full Text] [Related]
12. Prostate carcinoma metastatic to the cervical lymph nodes: report of two cases and review of the literature.
Copeland B; Clark JM; Sura A; Kilpatrick SE; Shockley W; Meredith S
Am J Otolaryngol; 2001; 22(6):420-3. PubMed ID: 11713729
[TBL] [Abstract][Full Text] [Related]
13. Prostatic adenocarcinoma presenting as isolated inguinal lymphadenopathy.
Doreswamy K; Karthikeyan VS; Nagabhushana M; Shankaranand B
BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26153290
[TBL] [Abstract][Full Text] [Related]
14. Biochemical Recurrence in Prostate Cancer and Temporal Association to Bone Metastasis.
Mahdy A; Patil R; Parajuli S
Am J Case Rep; 2019 Oct; 20():1521-1525. PubMed ID: 31615974
[TBL] [Abstract][Full Text] [Related]
15. The utility of PSMA and PSA immunohistochemistry in the cytologic diagnosis of metastatic prostate carcinoma.
Bernacki KD; Fields KL; Roh MH
Diagn Cytopathol; 2014 Jul; 42(7):570-5. PubMed ID: 24273068
[TBL] [Abstract][Full Text] [Related]
16. Prostate adenocarcinoma presenting with inguinal lymphadenopathy.
Huang E; Teh BS; Mody DR; Carpenter LS; Butler EB
Urology; 2003 Feb; 61(2):463. PubMed ID: 12597980
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor status of lymph node metastases from prostate cancer.
Hobisch A; Culig Z; Radmayr C; Bartsch G; Klocker H; Hittmair A
Prostate; 1996 Feb; 28(2):129-35. PubMed ID: 8604394
[TBL] [Abstract][Full Text] [Related]
18. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
19. Multiple pulmonary metastasis of prostatic carcinoma with little or no bone or lymph node metastasis. Report of two cases and review of the literature.
Kume H; Takai K; Kameyama S; Kawabe K
Urol Int; 1999; 62(1):44-7. PubMed ID: 10436432
[TBL] [Abstract][Full Text] [Related]
20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
